This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Apr;64(4):962-5.

doi: 10.1002/art.34362. Epub 2012 Jan 9.

The landscape after LUNAR: rituximab's crater-filled path

PMID: 22231618
DOI: 10.1002/art.34362

Editorial

The landscape after LUNAR: rituximab's crater-filled path

Liz Lightstone. Arthritis Rheum. 2012 Apr.

. 2012 Apr;64(4):962-5.

doi: 10.1002/art.34362. Epub 2012 Jan 9.

Author

PMID: 22231618
DOI: 10.1002/art.34362

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group. Rovin BH, et al. Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9. Arthritis Rheum. 2012. PMID: 22231479 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley